Matt Lipscomb, PHD

Boulder, Colorado, United States
Dr. Matt Lipscomb is CEO and Founder of DMC, Inc. His career has included a range of development stages from early R&D to commercial deployment in a variety of sectors, including both industrial and pharmaceutical biotechnology. Previously, he was a founding employee of OPX Biotechnologies and served in various roles during his tenure there. His technical leadership supported multiple successful fund raising rounds totaling more than $60M. He provided project leadership on the execution of a successful Department of Energy (DOE) ARPA-E Electrofuels program ($6M) for the production of biodiesel from H2 and CO2. His technical expertise includes microbial fermentation, process development, process modeling, analytical chemistry, and technoeconomic analysis (TEA) of bio-based processes.
Speaking In
12:00 PM - 12:45 PM (EDT)
Tuesday, September 22
Innovative technology producers are scaling at a rapid pace, deploying technology to partners and…
Interactive Online Session
[Available On-Demand]
At DMC, we produce bio-based chemicals using fermentation. Many chemicals are too expensive today…